National HealthCare Dirección

Dirección controles de criterios 3/4

El CEO de National HealthCare's es Steve Flatt , nombrado en Jan 2017, tiene una permanencia de 7.25 años. compensación anual total es $1.61M, compuesta por 32.8% salario y 67.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.39% de las acciones de la empresa, por valor de $5.49M. La antigüedad media del equipo directivo y de la junta directiva es de 7.1 años y 20.6 años, respectivamente.

Información clave

Steve Flatt

Chief Executive Officer (CEO)

US$1.6m

Compensación total

Porcentaje del salario del CEO	32.8%
Permanencia del CEO	7.3yrs
Participación del CEO	0.4%
Permanencia media de la dirección	7.2yrs
Promedio de permanencia en la Junta Directiva	20.7yrs

Actualizaciones recientes de la dirección

Recent updates

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

May 01

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Apr 09

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Mar 17

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 02

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Feb 15

Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year

Feb 02

Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?

Jan 20

These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong

Jan 07

Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend

Dec 25

What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay

Dec 24

Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?

Dec 12

Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Nov 30

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Steve Flatt en comparación con los beneficios de National HealthCare?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	US$81m
Dec 31 2023	US$2m	US$528k	US$67m
Sep 30 2023	n/a	n/a	US$45m
Jun 30 2023	n/a	n/a	US$32m
Mar 31 2023	n/a	n/a	US$19m
Dec 31 2022	US$1m	US$522k	US$22m
Sep 30 2022	n/a	n/a	US$32m
Jun 30 2022	n/a	n/a	US$31m
Mar 31 2022	n/a	n/a	US$133m
Dec 31 2021	US$2m	US$498k	US$139m
Sep 30 2021	n/a	n/a	US$150m
Jun 30 2021	n/a	n/a	US$167m
Mar 31 2021	n/a	n/a	US$90m
Dec 31 2020	US$1m	US$476k	US$42m
Sep 30 2020	n/a	n/a	US$28m
Jun 30 2020	n/a	n/a	US$35m
Mar 31 2020	n/a	n/a	US$20m
Dec 31 2019	US$1m	US$495k	US$68m
Sep 30 2019	n/a	n/a	US$73m
Jun 30 2019	n/a	n/a	US$74m
Mar 31 2019	n/a	n/a	US$83m
Dec 31 2018	US$1m	US$393k	US$59m
Sep 30 2018	n/a	n/a	US$62m
Jun 30 2018	n/a	n/a	US$52m
Mar 31 2018	n/a	n/a	US$41m
Dec 31 2017	US$1m	US$145k	US$56m

Compensación vs. Mercado: La compensación total de Steve($USD1.61M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD5.61M).

Compensación vs. Ingresos: La compensación de Steve ha aumentado más de un 20% en el último año.

CEO

Steve Flatt (67 yo)

7.3yrs

Permanencia

US$1,609,695

Compensación

Dr. Stephen F. Flatt, also known as Steve, has been the Chief Executive Officer of National HealthCare Corporation since January 1, 2017. Dr. Flatt served as the President of National Healthcare Corporatio...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Stephen Flatt	CEO & Director	7.3yrs	US$1.61m	0.39% $ 6.0m
R. Ussery	President & COO	15.3yrs	US$1.49m	1% $ 15.5m
Brian Kidd	Senior VP & CFO	no data	US$815.48k	0.15% $ 2.4m
B. Flatt	Senior VP & Chief Information Officer	7.3yrs	US$767.33k	0.079% $ 1.2m
Josh McCreary	Senior VP	5.1yrs	US$813.94k	0.036% $ 553.1k
Carl Adams	Founder	no data	sin datos	sin datos
Leroy McIntosh	Senior Vice President of Ancillary Services & Service Line Strategy	7.1yrs	sin datos	0.066% $ 1.0m
Vicki Dodson	Senior Vice President of Patient Services	4.9yrs	sin datos	0.045% $ 699.0k

7.2yrs

Permanencia media

61yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de NHC es experimentado (7.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Stephen Flatt	CEO & Director	7.3yrs	US$1.61m	0.39% $ 6.0m
W. Adams	Independent Director	50.3yrs	US$189.88k	4.54% $ 70.3m
Robert Adams	Independent Chairman	15.3yrs	US$192.88k	2.83% $ 43.8m
Richard LaRoche	Independent Director	22.3yrs	US$204.88k	2.31% $ 35.6m
Ernest Burgess	Independent Director	32.3yrs	US$192.88k	0.56% $ 8.6m
Emil Hassan	Independent Director	20.1yrs	US$196.88k	0.47% $ 7.3m
James Abernathy	Independent Director	21.3yrs	US$196.88k	0.23% $ 3.5m
Sandra Trail	Independent Director	2.3yrs	US$192.88k	0.023% $ 362.9k

20.7yrs

Permanencia media

76.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de NHC son experimentados ( 20.6 años antigüedad media).

National HealthCare Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Independent Director exercised options to buy US$312k worth of stock.

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Independent Director exercised options to buy US$131k worth of stock.

Recent updates

First quarter dividend increased to US$0.61

National Healthcare Corporation Declares Quarterly Dividend, Payable on August 1, 2024

First quarter 2024 earnings released: EPS: US$1.71 (vs US$0.76 in 1Q 2023)

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Upcoming dividend of US$0.59 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter dividend of US$0.59 announced

NHC Announces Quarterly Common Dividend, Payable on May 1, 2024

Independent Director exercised options to buy US$312k worth of stock.

Upcoming dividend of US$0.59 per share at 2.5% yield

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024

Independent Director exercised options to buy US$131k worth of stock.

Upcoming dividend of US$0.59 per share at 3.5% yield

Independent Chairman recently bought US$131k worth of stock

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2023

Independent Director recently bought US$129k worth of stock

Upcoming dividend of US$0.59 per share at 3.9% yield

Independent Director recently bought US$135k worth of stock

National HealthCare Corporation Announces Quarterly Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Upcoming dividend of US$0.57 per share at 4.1% yield

Independent Director recently bought US$125k worth of stock

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

National Healthcare Corporation Declares Quarterly Dividend, Payable on May 1, 2023

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$106k worth of stock.

Independent Director recently sold US$211k worth of stock

Insufficient new directors

National HealthCare Corporation Announces Quarterly Dividend, Payable on February 1, 2023

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$175k worth of stock.

National HealthCare Corporation (NYSEAM:NHC) announces an Equity Buyback for $25 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$0.21 (vs US$6.83 in 2Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2022

Upcoming dividend of US$0.57 per share

Independent Chairman exercised options to buy US$135k worth of stock.

Independent Director exercised options to buy US$529k worth of stock.

First quarter 2022 earnings released: EPS: US$0.99 (vs US$1.39 in 1Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 1, 2022

Insufficient new directors

Upcoming dividend of US$0.55 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

National Healthcare Corporation Announces Quarterly Dividend, Payable on May 2, 2022

National HealthCare Corporation Appoints Sandra Y. Trail to Its Board of Director, Effective February 1, 2022

Independent Director exercised options to buy US$350k worth of stock.

Upcoming dividend of US$0.55 per share

CEO & Director exercised options and sold US$132k worth of stock

Third quarter 2021 earnings released: US$0.22 loss per share (vs US$0.84 profit in 3Q 2020)

Upcoming dividend of US$0.52 per share

Second quarter 2021 earnings released: EPS US$6.83 (vs US$1.85 in 2Q 2020)

Upcoming dividend of US$0.52 per share

Independent Director exercised options to buy US$567k worth of stock.

First quarter 2021 earnings released: EPS US$1.39 (vs US$1.76 loss in 1Q 2020)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 2, 2021

Independent Director exercised options to buy US$527k worth of stock.

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Upcoming Dividend of US$0.52 Per Share

Independent Director recently sold US$151k worth of stock

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Chairman of the Board exercised options to buy US$210k worth of stock.